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Abstract
Background: Phenylpropanoids are the precursors to a range of important plant metabolites such
as the cell wall constituent lignin and the secondary metabolites belonging to the flavonoid/stilbene
class of compounds. The latter class of plant natural products has been shown to function in a wide
range of biological activities. During the last few years an increasing number of health benefits have
been associated with these compounds. In particular, they demonstrate potent antioxidant activity
and the ability to selectively inhibit certain tyrosine kinases. Biosynthesis of many medicinally
important plant secondary metabolites, including stilbenes, is frequently not very well understood
and under tight spatial and temporal control, limiting their availability from plant sources. As an
alternative, we sought to develop an approach for the biosynthesis of diverse stilbenes by
engineered recombinant microbial cells.
Results: A pathway for stilbene biosynthesis was constructed in Escherichia coli with 4-coumaroyl
CoA ligase 1 4CL1) from Arabidopsis thaliana and stilbene synthase (STS) cloned from Arachis
hypogaea. E. coli cultures expressing these enzymes together converted the phenylpropionic acid
precursor 4-coumaric acid, added to the growth medium, to the stilbene resveratrol (>100 mg/L).
Caffeic acid, added in the same way, resulted in the production of the expected dihydroxylated
stilbene, piceatannol (>10 mg/L). Ferulic acid, however, was not converted to the expected stilbene
product, isorhapontigenin. Substitution of 4CL1 with a homologous enzyme, 4CL4, with a
preference for ferulic acid over 4-coumaric acid, had no effect on the conversion of ferulic acid.
Accumulation of tri- and tetraketide lactones from ferulic acid, regardless of the CoA-ligase
expressed in E. coli, suggests that STS cannot properly accommodate and fold the tetraketide
intermediate to the corresponding stilbene structure.
Conclusion: Phenylpropionic acids, such as 4-coumaric acid and caffeic acid, can be efficiently
converted to stilbene compounds by recombinant E. coli cells expressing plant biosynthetic genes.
Optimization of precursor conversion and cyclization of the bulky ferulic acid precursor by host
metabolic engineering and protein engineering may afford the synthesis of even more structurally
diverse stilbene compounds.
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Background
Flavonoids and stilbenes are plant-specific natural prod-
ucts with a wide range of biological activities, such as UV
protection, as signals of bacterial root nodulation, colora-
tion and defense against herbivory and microbial patho-
gens[1,2]. The uncovering of an increasing number of
health benefits associated with these compounds has
resulted in an explosion of research on their medicinal
properties during the last few years[3,4]. In particular, the
stilbene compound resveratrol has received considerable
attention for its potential medicinal properties [5-7], and
has been identified as a compound promoting increased
lifespan through activation of sirtuin deacetylases[8],
although the exact effect of resveratrol on Sir2 family pro-
teins remains controversial[9,10]. Less controversial is the
effect of stilbenes on protein-tyrosine kinases, with picea-
tannol having been shown as a selective inhibitor of the
human tyrosine kinase Syk[11].
Flavonoids and stilbenes are synthesized from a coen-
zyme A (CoA) activated phenylpropanoid starter unit and
three malonyl-CoA extender units (Fig. 1). The first step in
phenylpropanoid biosynthesis is the deamination of L-
phenylalanine to trans-cinnamic acid, catalyzed by pheny-
lalanine ammonia lyase (PAL) (EC 4.3.1.5). Cinnamic
acid is hydroxylated by cinnamate-4-hydroxylase (C4H)
(EC 1.14.13.11) to make 4-coumaric acid, which is then
activated by 4-coumaroyl:CoA ligase (4CL) (EC 6.2.1.12)
to make 4-coumaroyl-CoA. A type III polyketide synthase
then sequentially adds three acetate extender units,
derived from malonyl-CoA, to a single activated 4-cou-
maroyl-CoA starter unit. Depending on the polyketide
synthase activity, chalcone synthase (CHS, EC 2.3.1.74) or
stilbene synthase (STS, EC 2.3.1.95), subsequent folding
and cyclization of the generated tetraketide intermediate
results either in the production of a chalcone or stilbene
ring structure.
Expression of plant secondary metabolic pathways,
including those for flavonoid and stilbene biosynthesis,
are typically under tight temporal and spatial control [12-
14], which limits the availability of many medicinally
important plant natural products. As an alternative bio-
synthetic host, microbial cells may be engineered for the
production of plant derived natural products. In an
attempt to access plant-derived flavonoid compounds in
engineered microbial cells, we have previously shown that
the Arabidopsis thaliana flavonoid biosynthetic pathway
can be functionally assembled in recombinant E. coli for
the biosynthesis of flavonoids[15]. Here we describe the
cloning of a stilbene synthase from Arachis hypogaea (pea-
nut) and its functional co-expression with two 4CL
enzymes for the biotransformation of phenylpropionic
acid precursors to modified stilbene compounds in E. coli.
Biotransformation of structurally diverse phenylpropi-
onic acids using recombinant E. coli opens up the possibil-
ity to produce functionalized stilbene compounds
without the need of additional biosynthetic enzymes that
may be difficult to express functionally in E. coli, such as
plant cytochrome P450 monooxygenases. We observe for
the first time production of two stilbene compounds by E.
coli, with the stilbene resveratrol produced at a level of
over 100 mg/L.
Results and discussion
Cloning and expression of A. hypogaea stilbene synthase 
(STS)
Stilbene synthases have been characterized from several
plant species, including Pinus sylvestris and A. hypogaea,
both of which have structural data reported[16,17]. For
the purpose of synthesizing structurally diverse stilbene
compounds in E. coli, we chose to use the STS from A.
hypogaea because of its reported broad substrate specifi-
city[18,19]. Peanut seeds were purchased from a commer-
cial supplier and grown for approximately two weeks
before preparation of cDNA. Two preparations of cDNA
were made, one from fully opened leaves and one from a
combination of roots and root hairs together. The cDNA's
were probed with gene specific [Genbank: AB027606]
primers, and a PCR product of the expected size (approx.
1200 bp) was only obtained from root cDNA, whereas the
leaf cDNA gave no detectable amplification product [see
Additional file 1]. The root cDNA PCR product was then
cloned into the expression vector pUCMod. This plasmid
was constructed by deletion of the pUC19 operator
sequence, which results in constitutive expression from
the lac promoter[20]. The sequence obtained for pUC-STS
was found to match the published sequences of sts from
peanut[21,22], but with several nucleotide changes. These
changes were conserved in three clones sequenced, sug-
gesting that the observed differences are the result of strain
variation. These nucleotide changes caused a few silent
mutations and nine changes in amino acid sequence
(G6E, V31I, G46S, N202S, N234K, Q245K, G281D,
K325N and T356E).
Expression of recombinant STS was determined by SDS-
PAGE, and the protein showed the expected molecular
weight of near 42 kDa (Fig. 2, lane 2). When total cellular
protein was separated into soluble and insoluble fractions
by high-speed centrifugation, STS appeared to be almost
entirely in the soluble fraction of the E. coli cell lysate,
with a small amount found in the insoluble fraction (Fig.
2, lanes 3–4). The high level of expressed soluble STS is
surprising as many plant derived genes are not well
expressed in E. coli without codon optimization to remove
rare or unusual plant codons. A reduced growth tempera-
ture of 30°C may have increased the solubility of the
recombinant protein[23]. Previous work on flavonoid
biosynthesis in E. coli also revealed a significant decreaseBMC Biotechnology 2006, 6:22 http://www.biomedcentral.com/1472-6750/6/22
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Engineered route to stilbene biosynthesis in E. coli Figure 1
Engineered route to stilbene biosynthesis in E. coli. Stilbene biosynthesis takes place by sequential addition of acetate 
units, derived from the decarboxylation of malonyl-CoA, to a CoA activated phenylpropionic acid. Polyketide intermediates (in 
brackets), if not cyclized properly, can be released from stilbene synthase (STS) and spontaneously form lactone derailment 
products. Acceptable starter units are extended to a linear tetraketide intermediate, which then undergoes aldol condensation 
and decarboxylation, followed by aromatization, to produce the proper stilbene structure. E. coli was engineered to produce 
stilbenes through the biotransformation of phenylpropionic acids by the enzymes 4-coumaroyl:CoA ligase 1 (4CL1) or 4-cou-
maroyl:CoA ligase 4 (4CL4) and STS. 4-coumaric acid and caffeic acid were transformed to the expected stilbene compounds, 
resveratrol and piceatannol, using this pathway. Ferulic acid was not converted to the corresponding stilbene using either 4CL1 
or 4CL4, but lactone derailment products were detected, indicating that this substrate can be used as a starter unit in vivo.BMC Biotechnology 2006, 6:22 http://www.biomedcentral.com/1472-6750/6/22
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in product titers when cells were cultivated in media con-
taining glucose due to decreased enzyme expression levels
(K. Watts, unpublished data). To investigate whether this
phenomenon was also important for recombinant stil-
bene biosynthesis, we cultivated E. coli pUC-STS in modi-
fied M9 containing glucose instead of glycerol. Expression
of STS in glucose containing media was significantly lower
(Fig. 2, lane 5–7), and was found exclusively in the solu-
ble protein fraction (Fig. 2, lane 6).
Biosynthesis of resveratrol in E. coli
During our previous studies on flavonoid biosynthesis in
E. coli, we observed that E. coli expressing a partial flavo-
noid pathway, consisting of 4CL1 and CHS, was able to
take up exogenous 4-coumaric acid and synthesize narin-
genin[15]. To identify conditions for the biotransforma-
tion of phenylpropionic acids to stilbenes in an analogous
reaction with 4CL1 and STS, E. coli was grown in the pres-
ence of increasing concentrations of 4-coumaric acid.
Strain BW27784 with empty plasmids (pACMod + pUC-
Mod) was used to mimic the culture conditions to be used
later for stilbene biosynthesis. As shown in Fig. 3, no
apparent growth inhibition was observed at 2 mM of
added 4-coumaric acid as the growth curve closely follows
that of the control culture without 4-coumaric acid at
both 24 and 48 hrs of growth. However, inhibition of
growth was observed at 6 mM, and at 20 mM of added 4-
coumaric acid, the optical density (OD, λ = 600 nm) is
reduced by approximately 38% after 24 hrs and 35% after
48 hrs. This effect is most likely due to 4-coumaric acid
itself, rather than a drop in culture pH caused by the
added phenylpropionic acid, as the pH of the cultures
after 48 hrs did not change more than 1.0 pH unit com-
pared to the control culture. Concentrations of 4-cou-
maric acid higher than 20 mM could not be easily
reproduced due to precipitation of substrate in the culture
media and on solid surfaces. Based upon these results, 1
mM was chosen as the phenylpropionic acid concentra-
tion for all subsequent biotransformation experiments.
To examine the function of the peanut STS in E. coli, pUC-
STS was transformed, along with pAC-4CL1, into E. coli
strain BW27784 and grown in modified M9 media with
glycerol. When the culture had grown to an OD of 0.1, 1
mM 4-coumaric acid was added. After 24 hrs growth at
30°C, the culture was extracted and analyzed for the
expected stilbene compound resveratrol. The HPLC pro-
file of the extract showed a peak with a retention time and
UV spectrum identical to authentic resveratrol (Fig. 4).
Control cultures of E. coli cells containing only pAC-4CL1
without STS, and supplemented with 1 mM 4-coumaric
acid, did not show the same peak. Similarly, no resveratrol
peak was detected in cultures of E. coli pAC-4CL1 + pUC-
STS without added 4-coumaric acid. Liquid chromatogra-
phy-mass spectrometry (LC-MS) analysis of this new com-
pound showed a parent ion (M-H+) mass matching an
authentic resveratrol standard (m/z  227.1). This result
demonstrates the first production of a stilbene compound
in a bacterial host. Flavonoid biosynthesis has previously
been reported in E. coli[15,24], but engineered stilbene
biosynthesis has not been reported in this organism. This
work therefore extends the range of plant polyketides that
can be produced in E. coli to include stilbenes. The pro-
duction of resveratrol in E. coli also opens up the possibil-
ity of engineering pathways for modified stilbene
biosynthesis. Rational extension of the pathway with
additional enzymes for methylation, glycosylation or pre-
nylation will greatly expand the range of compounds that
can be produced.
Kinetics of resveratrol biosynthesis
E. coli pAC-4CL1 + pUC-STS was grown in shake flasks to
determine growth and stilbene biosynthesis over time.
Cultures were grown in modified M9 with glycerol to an
OD of 0.1 when 1 mM 4-coumaric acid was added.
Growth and product formation were subsequently fol-
lowed for an additional 48 hours at 30°C. Resveratrol bio-
synthesis began almost immediately after addition of 4-
Expression of Arachis hypogaea STS in E. coli Figure 2
Expression of Arachis hypogaea STS in E. coli. SDS-
PAGE gel (12%) showing the overexpressed STS from peanut 
roots. The sts gene was cloned into the plasmid pUCMod as 
described in Materials and Methods. E. coli expressing STS, 
and a control culture with empty plasmid, were grown over-
night in modified M9 medium at 30°C containing glycerol 
(lanes 1–4) or glucose (lanes 5–7). Cell lysates were pre-
pared as described in Material and Methods. Samples are as 
follows: Lane 1: empty pUC control, Lane 2: pUC-STS grown 
in glycerol crude cell lysate, Lane 3: pUC-STS grown in glyc-
erol soluble protein fraction, Lane 4: pUC-STS grown in glyc-
erol insoluble protein fraction, Lane 5: pUC-STS grown in 
glucose crude cell lysate, Lane 6: pUC-STS grown in glucose 
soluble protein fraction and Lane 7: pUC-STS grown in glu-
cose insoluble protein fraction, Lane 8: molecular weight 
standard.BMC Biotechnology 2006, 6:22 http://www.biomedcentral.com/1472-6750/6/22
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coumaric acid and proceeded very quickly until all 4-cou-
maric acid present in the culture was consumed after
approximately 20 hrs (Fig. 5). After 19 hrs of growth,
104.5 ± 4.4 mg/L resveratrol was detected in the culture
media along with less than 2 mg/L 4-coumaric acid (Fig.
5). While 4-coumaric acid appeared to be completely con-
sumed in the reaction after 22 hrs, the maximum amount
of resveratrol detected corresponds to 460 µM, equal to a
46% conversion yield (mol/mol). Resveratrol levels
decreased after reaching the maximum of 104.5 ± 4.4 mg/
L at 19 hrs to 82.2 ± 6.8 mg/L after 48 hours, representing
a 22% loss of extractable product over the course of 19
hours. The fate of the remainder of the 4-coumaric acid
and the loss of extractable resveratrol are currently under
investigation.
When this same experiment was repeated with modified
M9 medium containing glucose, resveratrol production
was substantially decreased. Resveratrol levels again
reached a maximum value after approximately 20 hrs, but
the amount was reduced to 3.8 ± 0.6 mg/L compared to
104.5 ± 4.4 mg/L obtained with glycerol. This drop in res-
veratrol production is likely a consequence of reduced STS
expression in glucose containing M9 medium (Fig. 2,
lanes 5–7), but could also be due in part to a transport
phenomenon. Phenylpropionic acids are known to
Effect of increasing 4-coumaric acid concentrations on E. coli growth Figure 3
Effect of increasing 4-coumaric acid concentrations on E. coli growth. E. coli was grown in modified M9 medium con-
taining glycerol with increasing concentrations of 4-coumaric acid to determine growth inhibition. Concentrations of added 4-
coumaric acid were as follows: (● ) 0 mM, (■ ) 2 mM, (▲ ) 6 mM, (▼ ) 12 mM and () 20 mM. Growth was determined by OD 
measurement at 600 nm. Cultures were supplemented with varying concentrations of 4-coumaric acid once the starter culture 
reached an OD of 0.1. Data points represent the means of three independent measurements.BMC Biotechnology 2006, 6:22 http://www.biomedcentral.com/1472-6750/6/22
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induce expression of enzymes responsible for transport
and catabolism (hca  and  mhp  operons) of these com-
pounds in E. coli[25,26]. Additionally, expression of a reg-
ulatory protein (HcaR) controlling hydroxycinnamate
transport and catabolism (hca operon) is subject to cat-
abolite repression[25], suggesting that transport of phe-
nylpropanoids into E. coli during growth in media
containing glucose would be inhibited. This possibility is
currently under investigation.
Probing the biotransformation of diverse phenylpropionic 
acids by STS
To determine the range of compounds that could be pro-
duced in recombinant E. coli co-expressing 4CL1 and STS,
two additional phenylpropionic acid compounds were
tested as substrates: caffeic acid or ferulic acid (see Fig. 1
for structures). When E. coli pAC-4CL1 + pUC-STS was
grown in medium containing 1 mM caffeic acid, a new
peak was detected in a HPLC chromatogram of the extract
that was not present in an unsupplemented control cul-
ture. HPLC retention time, UV spectrum and parent ion
mass (m/z 243.1) of this new compound matched that of
the stilbene piceatannol (Fig. 6A). Detectable levels of
piceatannol reached 13.3 ± 0.3 mg/L after 24 hrs and 13.2
± 0.6 mg/L after 48 hrs of growth.
This result marks the first production of a dihydroxylated
stilbene in a recombinant host. The production of a stil-
bene from a dihydroxylated precursor (caffeic acid) is an
important step in the further development of E. coli for
stilbene biosynthesis as it circumvents the presumed cyto-
chrome P450 monooxygenase mediated hydroxylation of
resveratrol. While the enzyme catalyzing this reaction has
not been described in plants, in humans the reaction is
catalyzed by a cytochrome P450, CYP1B1[27]. Cyto-
chrome P450 enzymes have traditionally been difficult to
functionally express in E. coli due to a lack of a compatible
P450 reductase[28]. While functional plant P450 expres-
sion in E. coli may ultimately be accomplished, as it has in
yeast[29], it will most likely require extensive protein
engineering efforts, such as translational fusions to com-
patible reductases[30]. This finding also agrees with what
HPLC analysis of resveratrol Figure 4
HPLC analysis of resveratrol. E. coli expressing 4CL1 and STS was cultured in modified M9 medium with glycerol, and con-
taining 1 mM 4-coumaric acid, at 30°C for 24 hrs prior to extraction. Upper chromatogram shows extracted E. coli culture and 
bottom chromatogram shows resveratrol standard run under identical HPLC conditions. At right are the UV spectra for both 
recombinant resveratrol (1) (m/z 227.1) and resveratrol standard (2) (m/z 227.1). No residual 4-coumaric acid was detected by 
HPLC or LC-MS.BMC Biotechnology 2006, 6:22 http://www.biomedcentral.com/1472-6750/6/22
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has been seen in vitro with peanut STS and this substrate.
While 4-coumaric acid was reported to be the preferred
substrate for this enzyme (Km = 2 µM), caffeic acid was
also utilized to a small extent[31]. The relative amount of
piceatannol produced in vitro from caffeoyl-CoA was
approximately 12 fold lower than resveratrol produced
from an equivalent amount of 4-coumaroyl-CoA[31], and
this is in close proximity to what is seen in vivo with our E.
coli system.
The bulkier phenylpropionic acid substrate ferulic acid,
which has one of the two hydroxyl groups present in caf-
feic acid methylated, did not yield the corresponding fully
cyclized stilbene compound isorhapontigenin. Instead,
extracts from E. coli pAC-4CL1 + pUC-STS cultures supple-
mented with ferulic acid yielded two new peaks on HPLC
which were identified by mass spectrometry as the corre-
sponding triketide (m/z  259.1) and tetraketide (m/z
301.1) lactone intermediates (Fig. 6B). The major peak
observed in the ferulic acid supplemented culture extract,
however, always corresponded to unconverted ferulic
Growth and production curves for resveratrol biosynthesis Figure 5
Growth and production curves for resveratrol biosynthesis. Culture of E. coli pAC-4CL1 + pUC-STS was supple-
mented with 1 mM 4-coumaric acid and grown for approximately 48 hours in modified M9 medium with glycerol at 30°C. Sam-
ples were removed periodically for extraction to determine the consumption of the substrate 4-coumaric acid (❍ ) and the 
formation of the product resveratrol (● ). Growth (■ ) was monitored spectrophotometrically by measuring OD at 600 nm. 
Data points represent the mean of three independent measurements.BMC Biotechnology 2006, 6:22 http://www.biomedcentral.com/1472-6750/6/22
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HPLC analysis of cultures supplemented with caffeic acid or ferulic acid Figure 6
HPLC analysis of cultures supplemented with caffeic acid or ferulic acid. E. coli expressing 4CL1 and STS was supple-
mented with 1 mM substrate and grown in modified M9 medium at 30°C for 24 hrs prior to extraction. Panel A: Production 
of piceatannol from caffeic acid. Upper chromatogram shows extracted E. coli culture, bottom chromatogram shows piceatan-
nol standard run under identical HPLC conditions. At right are the UV spectra for both recombinant piceatannol (1) (m/z 
243.1) and piceatannol standard (2) (m/z 243.1). Peak 3 is residual caffeic acid (m/z 179.2). Panel B: E. coli expressing 4CL1 and 
STS supplemented with ferulic acid. Peak 1 corresponds to residual ferulic acid (m/z 193.1). Peak 2 corresponds to the ferulic 
acid derived tetraketide lactone (m/z 301.1) and peak 3 is the corresponding triketide lactone (m/z 259.1).BMC Biotechnology 2006, 6:22 http://www.biomedcentral.com/1472-6750/6/22
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acid, indicating that either substrate utilization by 4CL1 in
E. coli may be limiting or that the reaction of STS with fer-
uloyl-CoA is inefficient. In vitro, feruloyl-CoA was
reported to be converted to the corresponding stilbene,
albeit at low levels[31]. This suggested that the concentra-
tion of feruloyl-CoA was limiting in E. coli due to the CoA
ligase 4CL1.
Substitution of 4CL1 with the feruloyl-CoA ligase 4CL4
Ferulic acid is known to be a poor substrate for the 4CL1
enzyme from A. thaliana used in our studies[32]. How-
ever, a new 4CL1 homolog, 4CL4 from A. thaliana, was
recently shown to preferentially use ferulic acid and
sinapic acid as substrates[33]. Therefore, to investigate
whether the substrate specificity of 4CL1 was a limiting
step in stilbene biosynthesis from ferulic acid, 4CL4 was
cloned and co-expressed with STS. When E. coli pAC-4CL4
+ pUC-STS was grown in the presence of 1 mM ferulic
acid, no detectable isorhapontigenin was found by HPLC
or LC-MS analysis (data not shown). As with previous cul-
tures expressing 4CL1 and STS, similar amounts of
triketide and tetraketide lactones, and unconsumed feru-
lic acid, were detected. The presence of high levels of resid-
ual ferulic acid could indicate that the reaction of STS with
feruloyl-CoA is slow, causing an accumulation of feruloyl-
CoA, which can be converted back to ferulic acid by the
action of a soluble thioesterase, as has been observed dur-
ing attempts to purify aromatic CoA thioesters from E.
coli[34].
The result with 4CL4, along with the previous result with
4CL1, suggests that STS can use ferulic acid as a starter unit
in vivo, but it is unable to properly extend and fold the
intermediates formed, resulting in lactone derailment
products. These triketide and tetraketide lactones are typ-
ically found with unnatural substrates in CHS and STS in
vitro assays. The presence of lactone derailment products
demonstrates the ability of these enzymes to accept a wide
range of starter units, but due to limitations in the size of
the active site, they are not properly extended and/or
folded, and the resulting intermediates are released[35].
We have observed in vivo that CHS can also use ferulic acid
as a starter unit, and like STS, it does not properly fold the
intermediates, producing only the lactone derailment
products. Mutants of CHS designed to expand the active
site cavity, expressed together with 4CL4 in E. coli, pro-
duce differing ratios of triketide and tetraketide lactones in
vivo  (K. Watts, unpublished data). This suggests that
expansion of the STS active site cavity may similarly lead
to mutants that can more readily accommodate the larger
size of ferulic acid derived polyketide intermediates, and
eventually produce the properly folded stilbene structure.
Conclusion
For the first time, biosynthesis of stilbene compounds by
engineered  E. coli was demonstrated. The medicinally
important compound resveratrol was produced at a level
of over 100 mg/L in about 20 hrs of growth, at which time
4-coumaric acid was no longer detectable. This is a signif-
icantly higher yield of resveratrol than the 1–2 µg/L levels
previously reported for engineered Saccharomyces cerevi-
siae[36]. Analysis of protein expression data suggests that
the high level of soluble STS appears to be one likely rea-
son for this observation. The quantity of the stilbene
piceatannol produced from caffeic acid was also relatively
high, around 13 mg/L. While the amount of resveratrol
produced is quite high, the conversion yield is less than
50% from the added substrate 4-coumaric acid. This may
be partially explained by the capability of E. coli to
degrade aromatic acids, including phenylpropanoids[37].
Efforts are currently underway to elucidate the mecha-
nisms of substrate disappearance in order to gain insight
into phenylpropanoid transport and metabolism in E.
coli.
Ferulic acid was not converted to the corresponding stil-
bene structure, isorhapontigenin, by E. coli expressing
4CL1, or a ferulic acid specific CoA ligase, 4CL4, in con-
junction with STS. The use of 4CL4 was meant to over-
come the poor utilization of ferulic acid by 4CL1, but use
of 4CL4 had no apparent effect on product formation. It
would appear then that feruloyl-CoA utilization by STS is
the limiting step in the pathway. CHS likewise does not
produce a flavanone product from ferulic acid, but pro-
duces tri- and tetraketide lactones. Restricting the active
site cavity of CHS with this substrate produces increased
triketide lactone[38], suggesting that expansion of the
active site may have the opposite effect. Indeed, simple
mutations in CHS, and closely related enzymes, have
resulted in dramatic changes in substrate specificity and
product formation[35,39,40]. Since STS has been postu-
lated to have evolved from CHS[41], the ability to expand
and modify the active site of CHS may as well be possible
in STS.
This work opens up alternative routes for the production
of additional stilbene structures from phenylpropionic
acid precursors using recombinant E. coli cells. Through
manipulation of the biosynthetic enzymes controlling
product formation, and eliminating unwanted reactions
within the host, improvements may be seen that result in
efficient utilization of an expanded range of substrates.
Methods
Chemicals
Caffeic acid, ferulic acid and piceatannol were purchased
from Sigma Aldrich (St. Louis, MO). 4-coumaric acid was
purchased from ICN (Aurora, OH) and resveratrol wasBMC Biotechnology 2006, 6:22 http://www.biomedcentral.com/1472-6750/6/22
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from Calbiochem (San Diego, CA). All solvents used were
of HPLC grade and purchased from Fisher Scientific (Pitts-
burgh, PA). HPLC grade water was purchased from
Mallinckrodt Chemicals (Phillipsburg, NJ). T4 DNA ligase
and Vent DNA polymerase were from New England
Biolabs (NEB, Boston, MA). Restriction enzymes were
from NEB or Promega (Madison, WI) and restriction
enzyme buffers were the SuRE/Cut buffers from Roche
(Indianapolis, IN).
Strains and culture conditions
All cloning and DNA manipulations were carried out in E.
coli  strain JM109 by following standard techniques
described elsewhere[42]. After DNA sequencing, plasmids
were transformed into E. coli strain BW27784[43] (E. coli
Genetic Stock Center, New Haven, CT) for stilbene bio-
synthesis. E. coli cultures were grown at 30°C with 250
RPM shaking in a modified M9 or Luria-Bertani (LB)
medium, supplemented with carbenicillin or ampicillin
(100 mg/mL), and chloramphenicol (50 mg/mL), if nec-
essary. M9 medium was modified by addition of yeast
extract (1.25 g/L) and glycerol (0.5% v/v) or glucose (1%
v/v) into standard M9 medium [42].
Plant growth and cDNA preparation
A. hypogaea (peanut) seeds were purchased from Burpee
Seed Company (Warminster, PA). Plants were grown on a
well-lit window ledge, at approximately 23°C, for two
weeks prior to harvesting. Tissue samples were cut and fro-
zen immediately in liquid nitrogen and stored at -80°C
prior to use. mRNA was extracted using the Qiagen RNe-
asy Plant Mini Kit (Valencia, CA), followed by DNase I
digestion with the DNA-free Kit from Ambion (Austin,
TX). mRNA was annealed to oligo dT (Invitrogen,
Carlsbad, CA) during a single 65°C treatment for 5 min-
utes, put on ice, and followed by RT-PCR using Transcrip-
tor Reverse Transcriptase from Roche. Following the RT-
PCR step, cDNA was used immediately for subsequent
PCR.
Cloning and pathway assembly
Stilbene synthase (STS) was cloned from freshly prepared
root cDNA with gene specific primers designed from the
published sequence [22] [Genbank: AB027606]. Primers
included an XbaI site, followed by an optimized Shine-
Dalgarno sequence (5'-
TCTAGAAGGAGGATTACAAAATG3') and the start codon,
with 10–15 additional nucleotides from the gene
sequence immediately after the start codon. Reverse prim-
ers contained a NotI site for directional cloning into pUC-
Mod, a modified pUC19 plasmid with a deleted operator
sequence for constitutive expression from the lac  pro-
moter [20]. PCR was carried out with Vent DNA polymer-
ase and conditions were as follows: 94°C for 2 minutes,
30 cycles of 94°C for 30 seconds, 50°C for 30 seconds,
72°C for 1 minute followed by a final extension step at
72°C for 4 minutes. The resulting STS PCR product was
cloned into the XbaI and NotI sites of pUCMod to create
pUC-STS.
4CL4 was cloned from a commercial A. thaliana cDNA
library with primers designed from the published
sequence [33] [Genbank: AY376731]. Primers were
designed the same as above, with a 5' XbaI site and a 3'
NotI site for directional cloning into pUCMod to create
pUC-4CL4. PCR conditions were the same as described
above. 4CL4 was subcloned, along with the constitutive
lac promoter from pUC-4CL4, into the BamHI site of pAC-
Mod to create pAC-4CL4. 4CL1 was subcloned from
pBAD-4CL [15] into the NcoI site of pUCMod with gene
specific primers containing NcoI sites in both the forward
and reverse direction to create pUC-4CL1, which is also
transcribed from the constitutive lac promoter. PCR con-
ditions were the same as above. 4CL1 was later subcloned
to the BamHI site of pACMod to create pAC-4CL1.
Protein expression analysis
E. coli BW27784 was transformed with pUC-STS and
grown overnight at 30°C in 5 mL of modified M9 media
containing glycerol or glucose. This culture was used for
1:100 inoculation into 50 mL modified M9 containing
glycerol or glucose and grown at 30°C for an additional
24 hours. Cells were harvested by centrifugation at 4000 ×
g, washed with 10 mL of phosphate buffer (50 mM
NaPO4, pH 8.0) and the OD was determined at 600 nm.
Cells were diluted to equivalent ODs (1.0) with phos-
phate buffer and centrifuged. Cell pellets were resus-
pended in 10 mL phosphate buffer and lysed by
sonication (Branson, Danbury, CT). Lysate was centri-
fuged at 10,000 × g for 30 minutes to pellet insoluble
material. Following centrifugation, cleared lysate (10 mL)
was transferred to a fresh conical tube, and pelleted mate-
rial was resuspended in 10 mL fresh phosphate buffer.
Equal volumes (50 µL) from each fraction (crude, soluble
and insoluble) were removed and mixed with 50 µL SDS
running buffer and boiled briefly at 100°C. For gel analy-
sis, 10 µL of each sample mixture was loaded and run on
a 12% gel.
Substrate inhibition curves
For determination of growth inhibition by 4-coumaric
acid, 500 mL of E. coli BW27784 pACMod + pUCMod was
grown at 30°C to an OD of 0.1 – 0.2 and split into 5 flasks
containing 50 mL modified M9 medium with glycerol.
Growth media was supplemented with 0, 2, 6, 12 or 20
mM 4-coumaric acid in 200 µl DMSO. Cultures were
grown for an additional 48 hrs at 30°C, and this process
was repeated for three independent measurements. 1 mL
samples were removed periodically to record OD at 600
nm.BMC Biotechnology 2006, 6:22 http://www.biomedcentral.com/1472-6750/6/22
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Biotransformation
5 mL overnight cultures of E. coli pAC-4CL1 or pAC-4CL4
+ pUCMod or pUC-STS were inoculated 1:100 into 50 mL
modified M9 medium with glycerol containing chloram-
phenicol and carbenicillin. For biotransformation experi-
ments, 1 mM 4-coumaric acid, caffeic acid or ferulic acid
in 200 µl DMSO was added to E. coli cultures at an initial
OD of 0.1-0.2. Cultures grew for an additional 48 hrs at
30°C prior to harvest and extraction.
Growth and production curves
Overnight culture of E. coli pAC-4CL1 + pUC-STS was
inoculated 1:200 into 700 mL fresh modified M9 medium
containing glycerol or glucose, and supplemented with
chloramphenicol and carbenicillin. The culture was
grown to an OD of 0.1 – 0.2, split into three separate 500
mL flasks, each containing 200 mL of culture, and supple-
mented with 1 mM 4-coumaric acid. Growth was contin-
ued for an additional 48 hrs at 30°C and OD was
monitored at 600 nm. 1 mL samples were removed peri-
odically for analysis and quantification of 4-coumaric
acid and reaction products.
Extraction of culture media
Previous work had shown that less than 5% of products
and phenylpropionic acids were found in the cell pellets
[15], therefore only culture media was extracted. For
extraction, 1 mL of the culture was centrifuged at maxi-
mum speed (>13,000 RPM) to pellet cells. Media was
decanted to a fresh 1.5 mL microfuge tube and the pH was
adjusted by addition of 50 µl hydrochloric acid (1N), fol-
lowed by overnight freezing at -20°C. Tubes were thawed
at room temperature and extracted twice with an equal
volume (1 mL) of ethyl acetate. Ethyl acetate was dried
under nitrogen gas, and the dried residue was resus-
pended in 100 µL methanol. All samples were stored at -
20°C prior to HPLC and LC-MS analysis.
HPLC analysis
10 µl of extract was applied to a Zorbax RX-C18 column
(4.6 × 150 mm, 5 µm; Agilent Technologies, Palo Alto,
CA) using an Agilent 1100 HPLC system equipped with a
photodiode array detector. Resveratrol and ferulic acid
derived products were eluted with an isocratic mobile
phase of water containing 0.1% trifluoroacetic acid (A)
and methanol containing 0.1% trifluoroacetic acid (B) in
a ratio of 73:27 (A:B, v/v) with a flow rate of 1.0 mL/min.
Piceatannol was eluted with a flow rate of 0.5 mL/min
using the following conditions: from 0–10 min 75:25 A:B,
followed by a gradient from 75:25 A:B to 50:50 A:B in 15
minutes, followed by 5 min 50:50 A:B. Compound peaks
were identified by comparison to retention times and UV/
Vis spectra of standard compounds and mass spectrome-
try. For quantification of products, standard curves were
constructed by plotting peak areas of known quantities of
stilbene standards.
LC/ESI-MS analysis
LC-Mass spectrometry was carried out with a LCQ mass
spectrophotometer (Thermo Finnigan, USA) equipped
with a Zorbax RX-C18 column (4.6 × 250 mm, 5 µm; Agi-
lent) and eluted at 1.0 mL/min under isocratic conditions
of water:methanol (70:30). Mass fragmentation spectra of
standard compounds and the extracted compounds were
monitored in a mass range of m/z 100–500 with a nega-
tive electron spray ionization (ESI) interface as described
previously [15]. Negative ion values for standard com-
pounds were as follows: 4-coumaric acid (m/z 163.1), caf-
feic acid (m/z 179.1), ferulic acid (m/z 193.1), resveratrol
(m/z 227.1) and piceatannol (m/z 243.1).
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